FN2 Earnings Intelligence
Cigna Corporation financials
Cigna Corporation (CI) financial statements and key operating metrics from FN2 Research.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $5,081 | $5,924 | $7,822 | $7,550 | $7,676 | - | - |
| + Debt | $6,327 | $6,778 | $6,562 | $6,825 | $4,384 | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $174,078 | $180,516 | $195,265 | $247,121 | $274,900 | $284,838 | $297,054.6 |
| % Growth | 8.5% | 3.7% | 8.2% | 26.6% | 11.2% | 3.6% | 4.3% |
| Gross Profit | $56,525 | $55,682 | $61,464 | $64,612 | $59,909 | - | - |
| % Margin | 32.5% | 30.8% | 31.5% | 26.1% | 21.8% | - | - |
| EBITDA | $10,858 | $11,351 | $11,571 | $12,192 | $11,975 | - | - |
| % Margin | 6.2% | 6.3% | 5.9% | 4.9% | 4.4% | - | - |
| Net Income | $5,415 | $6,746 | $5,372 | $3,778 | $5,957 | - | - |
| % Margin | 3.1% | 3.7% | 2.8% | 1.5% | 2.2% | - | - |
| Diluted EPS | $15.73 | $21.30 | $17.39 | $12.12 | $22.18 | $30.45 | $33.46 |
| % Growth | -31.5% | 35.4% | -18.4% | -30.3% | 83.0% | 37.3% | 9.9% |
| Operating Cash Flow | $7,191 | $8,656 | $11,813 | $10,363 | $9,601 | - | - |
| CapEx | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $174,078 | $180,516 | $195,265 | $247,121 | $274,900 | $284,838 | $297,054.6 |
| Gross Profit | $56,525 | $55,682 | $61,464 | $64,612 | $59,909 | - | - |
| EBITDA | $10,858 | $11,351 | $11,571 | $12,192 | $11,975 | - | - |
| Net Income | $5,415 | $6,746 | $5,372 | $3,778 | $5,957 | - | - |
| Diluted EPS | $15.73 | $21.30 | $17.39 | $12.12 | $22.18 | $30.45 | $33.46 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $5,081 | $5,924 | $7,822 | $7,550 | $7,676 |
| Short-term Debt | $2,545 | $2,993 | $2,775 | $3,035 | $592 |
| Long-term Debt | $3,782 | $3,785 | $3,787 | $3,790 | $3,792 |
| Total Debt | $6,327 | $6,778 | $6,562 | $6,825 | $4,384 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $7,191 | $8,656 | $11,813 | $10,363 | $9,601 |
| Capital Expenditure | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Revenue Growth | 8.5% | 3.7% | 8.2% | 26.6% | 11.2% |
| Gross Margin | 32.5% | 30.8% | 31.5% | 26.1% | 21.8% |
| EBITDA Margin | 6.2% | 6.3% | 5.9% | 4.9% | 4.4% |
| Net Margin | 3.1% | 3.7% | 2.8% | 1.5% | 2.2% |
| FCF Margin | - | - | - | - | - |
| Diluted EPS Growth | -31.5% | 35.4% | -18.4% | -30.3% | 83.0% |